Skip to main content
. 2022 Jan 18;12:805656. doi: 10.3389/fgene.2021.805656

FIGURE 7.

FIGURE 7

Results from overall survival (OS) analysis comparing the survival time of breast cancer patients possessing a mutated or un-mutated Muc16 gene. The difference between the two groups (with and without mutations in Muc16 gene) is significant among young (under 45 years of age) individuals (p-value = 0.011), while not significant in older patients (p-value = 0.14).